特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂（CAS 402957-28-2）：分子式 C36H53N7O6、分子量 679.8。
| CAS号 | 402957-28-2 |
|---|---|
| 分子式 | C36H53N7O6 |
| 分子量 | 679.8 |
| LogP | 4.2 |
| 应用领域 | Uses: MEDICATION、Antiviral against hepatitis C、Formulations、Preparations: INCIVEK (telaprevir) is supplied as purple film-coated capsule-shaped tablets containing 375 mg of telaprevir. Each tablet is debossed with the characters "V 375" on one side and is packaged as follows: 28-day packer contains 4 weekly cartons of 7 blister strips each (6 tablets per blister strip) |
登记用途：Uses: MEDICATION、Antiviral against hepatitis C、Formulations、Preparations: INCIVEK (telaprevir) is supplied as purple film-coated capsule-shaped tablets containing 375 mg of telaprevir. Each tablet is debossed with the characters "V 375" on one side and is packaged as follows: 28-day packer contains 4 weekly cartons of 7 blister strips each (6 tablets per blister strip)。
特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂 是一种化工化合物，登记 CAS 号为 402957-28-2，分子式 C36H53N7O6（分子量 679.8）。
登记 CAS 号：402957-28-2
其分子式 C36H53N7O6 由 36 个碳、53 个氢、7 个氮、6 个氧 组成。
别名/同义词：特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂 · Cyclopenta(c)pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydro-, (1S,3aR,6aS)-
特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂 的 CAS 登记号为 402957-28-2。
分子式 C36H53N7O6，分子量 679.8。
别名/同义词：特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂、Cyclopenta(c)pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydro-, (1S,3aR,6aS)-。
登记用途：Uses: MEDICATION、Antiviral against hepatitis C、Formulations、Preparations: INCIVEK (telaprevir) is supplied as purple film-coated capsule-shaped tablets containing 375 mg of telaprevir. Each tablet is debossed with the characters "V 375" on one side and is packaged as follows: 28-day packer contains 4 weekly cartons of 7 blister strips each (6 tablets per blister strip)。
特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂（CAS 402957-28-2）的独立参考数据，整理自公开化学数据库。
| CAS 号 | 402957-28-2 |
|---|---|
| PubChem CID | 3010818 |
| 分子式 | C36H53N7O6 |
| IUPAC 名称 | (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide |
| UNII（FDA） | 655M5O3W0U |
| Molecular Weight | 679.8 |
|---|---|
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 14 |
| Exact Mass | 679.40573244 |
| Monoisotopic Mass | 679.40573244 |
| Topological Polar Surface Area | 180 |
| Heavy Atom Count | 49 |
| Solubility | 0.0047 |
|---|---|
| Solubility | In water, 0.0047 mg/mL |
| Solubility | 3.55e-02 g/L |
Telaprevir; 402957-28-2; VX-950; Incivek; Incivo; MP-424; VX 950; LY-570310; MP 424; VRT 111950; VRT-111950; VX950 cpd; LY 570310; CHEBI:68595; 655M5O3W0U; DTXSID40193304
| GHS 通报统计 | 9.1% (1 / 11) |
|---|
| GHS 通报统计 | 9.1% (1 / 11) |
|---|---|
| 已通报的危害声明 | H302 (90.9%) |
特拉匹韦, 丙型肝炎病毒(HCV)NS3-4A丝氨酸蛋白酶抑制剂 · CAS 402957-28-2 · C36H53N7O6. UNII 655M5O3W0U. Solubility: 0.0047; Solubility: In water, 0.0047 mg/mL; Solubility: 3.55e-02 g/L.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。